Satoshi Teramukai

Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02 (2009)

Nakagawa, Masatsugu, Nishimura, Tsutomu, Teramukai, Satoshi, Tada, Harue, Tanaka, Fumihiro, Yanagihara, Kazuhiro, ...

Abstract Background In Japan, high incidences of interstitial lung disease (ILD) and ILD-related deaths have been reported among gefitinib-treated patients with non-small cell lung cancer (NSCLC). We...

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03 (2009)

Teramukai, Satoshi, Kitano, Toshiyuki, Kishida, Yusuke, Kawahara, Masaaki, Kubota, Kaoru, Komuta, Kiyoshi, ...

We examined the impact of pretreatment neutrophil count on survival in patients with advanced non-small-cell lung cancer (NSCLC). A total of 388 chemo-naive patients with stage IIIB or IV NSCLC from...

Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma (2009)

Tada, Harue, Teramukai, Satoshi, Fukushima, Masanori, Sasaki, Hiroshi

Abstract Background Lymph node dissection has proven prognostic benefits for patients with ovarian or uterine carcinoma; however, one of the complications associated with this procedure is...

The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery (2008)

Kiba, Takayoshi, Inamoto, Takashi, Nishimura, Tsutomu, Ueno, Masaya, Yanagihara, Kazuhiro, Teramukai, Satoshi, ...

Abstract Backgrounds Prognostic factors are defined as biological or clinical measurement associated with overall survival and/or disease-free survival. Previous studies have shown that patients with...

Serial Assessment of Immune Status by Circulating CD8+ Effector T Cell Frequencies for Posttransplant Infectious Complications (2008)

Shinji Uemoto, Kazue Ozawa, Hiroto Egawa, Yasutsugu Takada, Hiroshi Sato, Satoshi Teramukai, ...

To clarify the role of CD8+ effector T cells for infectious complications, 92 recipients were classified according to the hierarchical clustering of preoperative CD8+CD45 isoforms: Group I was naive,...

Serial Assessment of Immune Status by Circulating CD8+ Effector T Cell Frequencies for Posttransplant Infectious Complications (2008)

Shinji Uemoto, Kazue Ozawa, Hiroto Egawa, Yasutsugu Takada, Hiroshi Sato, Satoshi Teramukai, ...

To clarify the role of CD8+ effector T cells for infectious complications, 92 recipients were classified according to the hierarchical clustering of preoperative CD8+CD45 isoforms: Group I was naive,...

Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures. (2006)

Nishimura, Tsutomu, Tada, Harue, Nakagawa, Masatsugu, Teramukai, Satoshi, Matsui, Shigeyuki

Objective: The objective of this study was to identify problems in the approval, pharmacovigilance, and post-approval regulatory decision-making procedures involving gefitinib and to propose...

Individual Patient-level and Study-level Meta-analysis for Investigating Modifiers of Treatment Effect (2004)

Teramukai, Satoshi, Matsuyama, Yutaka, Mizuno, Sachiko, Sakamoto, Junichi

Background: In meta-analyses of clinical trials, clinicians are often interested in examining subset effects. Meta-regression of aggregated data is a usual approach for relating sources of variation...

Data Handling in Cancer Clinical Trials--How We Can Minimize Potential Biases (2002)

Sakamoto, Junichi, Teramukai, Satoshi

Anthropometric and Behavioral Correlates of Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 in Middle-aged Japanese Men (2002)

Teramukai, Satoshi, Rohan, Thomas, Eguchi, Hiroyuki, Oda, Takashi, Shinchi, Koichi, Kono, Suminori

High levels of plasma insulin-like growth factor I (IGF-I) and low levels of insulin-like growth factor binding protein 3 (IGFBP-3) have been related to increased risk of several cancers. Little is...

Serial Assessment of Immune Status by Circulating CD8+ Effector T Cell Frequencies for Posttransplant Infectious Complications

Uemoto, Shinji, Ozawa, Kazue, Egawa, Hiroto, Takada, Yasutsugu, Sato, Hiroshi, Teramukai, Satoshi, ...

To clarify the role of CD8+ effector T cells for infectious complications, 92 recipients were classified according to the hierarchical clustering of preoperative CD8+CD45 isoforms: Group I was naive,...

The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery

Kiba, Takayoshi, Inamoto, Takashi, Nishimura, Tsutomu, Ueno, Masaya, Yanagihara, Kazuhiro, Teramukai, Satoshi, ...

Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma

Tada, Harue, Teramukai, Satoshi, Fukushima, Masanori, Sasaki, Hiroshi

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes

Ishida, Takanori, Kiba, Takayoshi, Takeda, Motohiro, Matsuyama, Kotone, Teramukai, Satoshi, Ishiwata, Ryota, ...

Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02

Nakagawa, Masatsugu, Nishimura, Tsutomu, Teramukai, Satoshi, Tada, Harue, Tanaka, Fumihiro, Yanagihara, Kazuhiro, ...